Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT05371756
Eligibility Criteria:
Inclusion Criteria:
* Understand and willingness to sign written informed consent method.
* Patients who are suspected by a physician of being at risk for developing cancer.
* Patients with confirmed or clinically suspected malignancy by a physician. This includes but is not limited to candidates for immunotherapy, surgical candidates, patients receiving Standard of Care drugs, immunotherapy drugs, participating on a clinical trial with immunotherapy drugs, patients who have received immunotherapy drugs in the past, patients with any other approved or investigational disease management.
Exclusion Criteria:
* Patients unwilling to donate blood
* Patients unwilling to provide informed consent for the collection of fresh or archived tumor tissue.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT05371756
Study Brief:
Protocol Section:
NCT05371756